CRT 2025

Abstract Session

Real-world Comparison Of Standard Vs. Reduced-dose Apixaban In Stroke Prevention And Bleeding Risk In Atrial Fibrillation Patients With Chronic Kidney Disease: A Retrospective Analysis Of Trinetx Data

Speaker(s)

• 

  Sameh Gomaa, MD

  Resident
  Tower health Phoenixville Hospital

  Disclosure(s): No financial relationships to disclose